These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19137216)

  • 41. Comparison between bioconcentration factor (BCF) data provided by industry to the European Chemicals Agency (ECHA) and data derived from QSAR models.
    Petoumenou MI; Pizzo F; Cester J; Fernández A; Benfenati E
    Environ Res; 2015 Oct; 142():529-34. PubMed ID: 26282223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR Use in REACH Analyses of Alternatives to Predict Human Health and Environmental Toxicity of Alternative Chemical Substances.
    Chinen K; Malloy T
    Integr Environ Assess Manag; 2020 Sep; 16(5):745-760. PubMed ID: 32162772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Responsibilities of enterprises introducing new dangerous chemical substances and preparations].
    Cieśla J; Majka J
    Med Pr; 2004; 55(1):81-6. PubMed ID: 15156771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).
    Rovida C; Hartung T
    ALTEX; 2009; 26(3):187-208. PubMed ID: 19907906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for PBT chemicals among the "existing" and "new" chemicals of the EU.
    Strempel S; Scheringer M; Ng CA; Hungerbühler K
    Environ Sci Technol; 2012 Jun; 46(11):5680-7. PubMed ID: 22494215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?
    Rovida C; Longo F; Rabbit RR
    ALTEX; 2011; 28(4):273-94. PubMed ID: 22130481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving REACH.
    Rudén C; Hansson SO
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):33-42. PubMed ID: 16256254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (Q)SARs as Adaptations to REACH Information Requirements.
    Alasuvanto T; Gissi A; Sobanski T; Karamertzanis P; Rasenberg M
    Methods Mol Biol; 2018; 1800():107-115. PubMed ID: 29934889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Narrow-and-sharp or broad-and-blunt--regulations of hazardous chemicals in consumer products in the European Union.
    Molander L; Rudén C
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):523-31. PubMed ID: 22107914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving uncertainty analysis in European Union risk assessment of chemicals.
    Verdonck FA; Souren A; van Asselt MB; Van Sprang PA; Vanrolleghem PA
    Integr Environ Assess Manag; 2007 Jul; 3(3):333-43. PubMed ID: 17695106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. European activities in radiation protection in medicine.
    Simeonov G
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):34-8. PubMed ID: 25870434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chemical compound safety: typology of competency accreditation for assay centers and analytical laboratories].
    Menditto A; Chiodo F
    Ann Ist Super Sanita; 2002; 38(1):77-85. PubMed ID: 12122899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of REACH: Issues Involved in the Registration of Metals.
    Armstrong V; Karyakina NA; Nordheim E; Arnold I; Krewski D
    Neurotoxicology; 2021 Mar; 83():186-198. PubMed ID: 32057950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of REACH legislation on the production and importation of CMR (carcinogen, mutagen and reproductive) and explosive chemicals in Italy from 2011 to 2015.
    Marzo M; Leone C; Toma C; Roncaglioni A; Gianazzi S; Knauf R; Benfenati E
    Regul Toxicol Pharmacol; 2019 Feb; 101():166-171. PubMed ID: 30502361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the proposed EU regulation concerning biocide products and its opportunities for alternative approaches and a toxicology for the 21st century.
    Ferrario D; Rabbit RR
    ALTEX; 2012; 29(2):157-72. PubMed ID: 22562488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derived no-effect levels (DNELs) under the European chemicals regulation REACH--an analysis of long-term inhalation worker-DNELs presented by industry.
    Schenk L; Deng U; Johanson G
    Ann Occup Hyg; 2015 May; 59(4):416-38. PubMed ID: 25471229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.